| Autor: |
Zacksenhaus, Eldad, Shrestha, Mariusz, Liu, Jeff C., Vorobieva, Ioulia, Chung, Philip E.D., Ju, YoungJun, Nir, Uri, Jiang, Zhe |
| Zdroj: |
Trends in Cancer; November 2017, Vol. 3 Issue: 11 p768-779, 12p |
| Abstrakt: |
A switch from catabolic to anabolic metabolism, a major hallmark of cancer, enables rapid cell duplication, and is driven by multiple oncogenic alterations, including PIK3CA mutation, MYC amplification, and TP53 loss. However, tumor growth requires active mitochondrial function and oxidative phosphorylation (OXPHOS). Recently, loss of the retinoblastoma (RB1) tumor suppressor in breast cancer was shown to induce mitochondrial protein translation (MPT) and OXPHOS. Here, we discuss how increased OXPHOS can enhance anabolic metabolism and cell proliferation, as well as cancer stemness and metastasis. Mitochondrial STAT3, FER/FER-T, and CHCHD2 are also implicated in OXPHOS. We propose that RB1loss represents a prototypic oncogenic alteration that promotes OXPHOS, that aggressive tumors acquire lethal combinations of oncogenes and tumor suppressors that stimulate anabolism versus OXPHOS, and that targeting both metabolic pathways would be therapeutic. |
| Databáze: |
Supplemental Index |
| Externí odkaz: |
|
